Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma

Epigenetic regulation of tumor suppressor genes (TSGs) has been shown to play a central role in melanomagenesis. By integrating gene expression and methylation array analysis we identified novel candidate genes frequently methylated in melanoma. We validated the methylation status of the most promising genes using highly sensitive Sequenom Epityper assays in a large panel of melanoma cell lines and resected melanomas, and compared the findings with those from cultured melanocytes. We found transcript levels of UCHL1, COL1A2, THBS1 and TNFRSF10D were inversely correlated with promoter methylation. For THBS1 and UCHL1 the effect of this methylation on expression was confirmed at the protein level. Identification of these candidate TSGs and future research designed to understand how their silencing is related to melanoma development will increase our understanding of the etiology of this cancer and may provide tools for its early diagnosis

Effects of temperature on the crystal structure of epidote: a neutron single-crystal diffraction study at 293 and 1070K

The effects of temperature on the crystal structure of a natural epidote [Ca1.925 Fe0.745Al2.265Ti0.004Si3.037O12(OH), a = 8.890(6), b = 5.630(4), c = 10. 50(6) \uc5 and \u3b2 = 115.36(5)\ub0, Sp.Gr. P21/m] have been investigated by means of neutron single-crystal diffraction at 293 and 1,070 K. At room conditions, the structural refinement confirms the presence of Fe3+ at the M3 site [%Fe(M3) = 73.1(8)%] and all attempts to refine the amount of Fe at the M(1) site were unsuccessful. Only one independent proton site was located. Two possible hydrogen bonds, with O(2) and O(4) as acceptors [i.e. O(10)-H(1)\ub7\ub7\ub7O(2) and O(10)-H(1)\ub7\ub7\ub7O(4)], occur. However, the topological configuration of the bonds suggests that the O(10)-H(1)\ub7\ub7\ub7O(4) is energetically more favourable, as H(1)\ub7\ub7\ub7O(4) = 1.9731(28) \uc5, O(10)\ub7\ub7\ub7O(4) = 2.9318(22) \uc5 and O(10)-H(1)\ub7\ub7\ub7O4 = 166.7(2)\ub0, whereas H(1)\ub7\ub7\ub7O(2) = 2.5921(23) \uc5, O(10)\ub7\ub7\ub7O(2) = 2.8221(17)\uc5 and O(10)-H(1)\ub7\ub7\ub7O2 = 93.3(1)\ub0. The O(10)-H(1) bond distance corrected for "riding motion" is 0.9943 \uc5. The diffraction data at 1,070 K show that epidote is stable within the T-range investigated, and that its crystallinity is maintained. A positive thermal expansion is observed along all the three crystallographic axes. At 1,070 K the structural refinement again shows that Fe3+ share the M(3) site along with Al3+ [%Fe(M3)1,070K = 74(2)%]. The refined amount of Fe3+ at the M(1) is not significant [%Fe(M1)1,070K = 1(2)%]. The tetrahedral and octahedral bond distances and angles show a slight distortion of the polyhedra at high-T, but a significant increase of the bond distances compared to those at room temperature is observed, especially for bond distances corrected for "rigid body motions". The high-T conditions also affect the inter-polyhedral configurations: the bridging angle Si(2)-O(9)-Si(1) of the Si2O7 group increases significantly with T. The high-T structure refinement shows that no dehydration effect occurs at least within the T-range investigated. The configuration of the H-bonding is basically maintained with temperature. However, the hydrogen bond strength changes at 1,070 K, as the O(10)\ub7\ub7\ub7O(4) and H(1)\ub7\ub7\ub7O(4) distances are slightly longer than those at 293 K. The anisotropic displacement parameters of the proton site are significantly larger than those at room condition. Reasons for the thermal stability of epidote up to 1,070 K observed in this study, the absence of dehydration and/or non-convergent ordering of Al and Fe3+ between different octahedral sites and/or convergent ordering on M(3) are discussed

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

Cutaneous melanoma is a very aggressive neoplasia of melanocytic origin with constantly growing incidence and mortality rates world-wide. Epigenetic modifications (i.e., alterations of genomic DNA methylation patterns, of post-translational modifications of histones, and of microRNA profiles) have been recently identified as playing an important role in melanoma development and progression by affecting key cellular pathways such as cell cycle regulation, cell signalling, differentiation, DNA repair, apoptosis, invasion and immune recognition. In this scenario, pharmacologic inhibition of DNA methyltransferases and/or of histone deacetylases were demonstrated to efficiently restore the expression of aberrantly-silenced genes, thus re-establishing pathway functions. In light of the pleiotropic activities of epigenetic drugs, their use alone or in combination therapies is being strongly suggested, and a particular clinical benefit might be expected from their synergistic activities with chemo-, radio-, and immuno-therapeutic approaches in melanoma patients. On this path, an important improvement would possibly derive from the development of new generation epigenetic drugs characterized by much reduced systemic toxicities, higher bioavailability, and more specific epigenetic effects